Cannabinoids can be classified into those found naturally in the body (endocannabinoids), those made artificially (synthetic cannabinoids) or those derived from extracts from the plant cannabis sativa (phytocannabinoids).
The research, announced at the annual UK Stroke Forum, indicates that all three classes of cannabinoid could be effective in shrinking the area of the brain affected by stroke and in recovering neurological function.
Dr Tim England, Honorary Consultant Stroke Physician at the University of Nottingham and Royal Derby Hospital led the study. He said: "This meta-analysis of pre-clinical stroke studies provides valuable information on the existing, and importantly, missing data on the use of cannabinoids as a potential treatment for stroke patients. The data are guiding the next steps in experimental stroke in order to be able to progress onto initial safety assessments in a clinical trial."
Read More: MedicalXPress
